| Authors: |
Wahlster L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Godley LA; Division of Hematology/Oncology, Lurie Children's Hospital, Northwestern Medicine, Chicago, IL., Cheng JX; Department of Pathology, The University of Chicago, Chicago, IL., Drazer MW; Sections of Hematology/Oncology and Genetic Medicine, Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL., Reilly CR; Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rowe JH; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Weichert-Leahey N; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rowe RG; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gorfinkel L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Brundige K; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wachter F; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Messa L; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Michelson AD; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Cantor AB; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Shimamura A; Division of Hematology/Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Bledsoe JR; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA. |
